Oculyze & BIOTECON Diagnostics sign strategic partnership
Oculyze and BIOTECON Diagnostics announced the signing of a strategic partnership. The agreement signed at the corporate offices of BIOTECON Diagnostics in Potsdam, appoints the Company as the exclusive global distributor of Oculyze’s latest technological innovation the Oculyze Better Brewing (BB) 2.0
Seen in the picture from left to right is Kilian Moser, co-founder and Chief Executive Officer of Oculyze and Alois Schneiderbauer, Chief Business Officer of BIOTECON Diagnostics
Oculyze GmbH
The Oculyze BB 2.0, a quality German made hardware/software combination, enables breweries to determine viability and concentration of their yeast in less than a minute. It is compact, weighing under 200 g and can easily fit within the palm of a brewer's hand. The technology comes equipped with a high quality optical scope that is comparable to a high end laboratory microscope and is compatible with most android mobile phones and tablets.
Signing the agreement, Kilian Moser, co-founder and Chief Executive Officer of Oculyze said: “I am delighted to announce this strategic partnership with BIOTECON Diagnostics as we look torapidly build and consolidate the Oculyze BB 2.0 market share and brand value across the world. As a relatively young and innovative biotech firm, we believe in focusing on our core strengths to continuously create and roll out key technological solutions that are smart, easy to use and cost efficient. By entrusting BIOTECON Diagnostics to manage the global distribution of our flagship product, we are confident of capitalizing on their strengths towards offering the Oculyze BB 2.0 to an even wider audience. BIOTECON Diagnostics brings a wealth of experience within the area of sales and distribution by cooperating with leading international manufacturers, and we look forward to the beginning of a mutually beneficial and successful partnership.”
Speaking on behalf of BIOTECON Diagnostics, Alois Schneiderbauer, Chief Business Officer of BIOTECON Diagnostics said: "BIOTECON Diagnostics is proud of the long-standing relationships that have been built up over the years with various partners, alsoin the brewing sector, and we continue to focus on expanding our product portfolio. We are, therefore,pleased to have the confidence to add the Oculyze BB 2.0 to our global portfolio as we also believe in the technology and advantageof the product and have many common interests with Oculyze. We lookforward to further developing this relationship and contributing to the establishment and market presence of the Oculyze BB 2.0".
Other news from the department business & finance
These products might interest you
JEOL CRYO ARM by JEOL
Cryo-TEM: Fast and stable data acquisition for biosamples
Increased efficiency in structural biology with automated sample loading system
FLUOVIEW FV4000 by EVIDENT
Revolutionary imaging with FLUOVIEW FV4000: Confocal laser scanning
Utilise AI-powered image processing and innovative detector technology
alpha300 R by WITec
3D Raman microscopes with unequalled speed, sensitivity and resolution
Visualize and characterize every chemical detail
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Most read news
More news from our other portals
Something is happening in the life science industry ...
This is what true pioneering spirit looks like: Plenty of innovative start-ups are bringing fresh ideas, lifeblood and entrepreneurial spirit to change tomorrow's world for the better. Immerse yourself in the world of these young companies and take the opportunity to get in touch with the founders.
